Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 study
卡非佐米、来那度胺和地塞米松联合疗法治疗复发/难治性多发性骨髓瘤患者可获得更佳疗效并改善高危因素:多中心 KMMWP2201 研究结果
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2024.285534
Lee, Ji Hyun; Choi, Jimin; Min, Chang-Ki; Park, Sung-Soo; Jo, Jae-Cheol; Lee, Yoo Jin; Kim, Jin Seok; Eom, Hyeon-Seok; Jung, Jongheon; Moon, Joon Ho; Cho, Hee Jeong; Lee, Myung-Won; Yoon, Sung-Soo; Byun, Ja Min; Lee, Jae Hoon; Lee, Je-Jung; Jung, Sung-Hoon; Shin, Ho-Jin; Kim, Do Young; Yi, Jun Ho; Lee, Seung-Shin; Do, Young Rok; Yoon, Dok Hyun; Cho, Hyungwoo; Lee, Won Sik; Lee, Ho Sup; Uhm, Jieun; Kim, Hyo Jung; Jang, Hee Ryeong; Kim, Sung-Hyun; Kim, Kihyun